SEC Form 5 · accession 0001144204-16-080469
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory M Sullivan
Officer — Chief Medical Officer
Period of report
Dec 31, 2015
Accepted (ET)
Feb 10, 2016 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2015 | J | 3,532 | $4.99 | A | 20,457 | D | |
| Common Stock | Dec 31, 2015 | J | 2,728 | $6.46 | A | 23,185 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired through the Tonix Pharmaceuticals Holding Corp. Employee Stock Purchase Plan.